ArticleWorld journal of surgical oncology2012
Primary pulmonary mucoepidermoid carcinoma: an analysis of 21 cases.
Article in World journal of surgical oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 53 citations in OpenAlex.
- Article
- A surgical strategy-based nomogram for primary pulmonary mucoepidermoid carcinoma.Discover oncology · 2025Article
- Lorlatinib in the treatment of a rare pulmonary mucoepidermoid carcinoma with EML4-ALK fusion: a case report and literature review.Frontiers in oncology · 2024Article
- Pulmonary mucoepidermoid carcinoma in children: two case reports and a review of the literature.Frontiers in pediatrics · 2023Article
- Metastatic mucoepidermoid carcinoma to the pleura: a case report.Journal of medical case reports · 2022Article
- Pulmonary Salivary Gland Tumor, Mucoepidermoid Carcinoma: A Literature Review.Journal of oncology · 2022Review
- Nomogram for predicting the survival rate of primary pulmonary mucoepidermoid carcinoma patients: a retrospective study based on SEER database.Annals of translational medicine · 2021Article
- Clinical Characteristics and Prognosis of Patients With Pulmonary Mucoepidermoid Carcinoma: A SEER-Based Analysis.Frontiers in oncology · 2021Article
- Pulmonary mucoepidermoid lung carcinoma in pediatric confused with asthma.Respiratory medicine case reports · 2021Article
- Photodynamic therapy for pulmonary mucoepidermoid carcinoma.Respiratory medicine case reports · 2021Article
- Article
- Rare cause of lung atelectasis in a young woman.BMJ case reports · 2019Article
- Radiological and Clinical Features and Outcomes of Patients with Primary Pulmonary Salivary Gland-Type Tumors.Canadian respiratory journal · 2019Article
- A Rare Case of Pulmonary Mucoepidermoid Carcinoma in an 81-Year-Old Male.The American journal of case reports · 2018Article
- CT features and differential diagnosis of primary pulmonary mucoepidermoid carcinoma and pulmonary adenoid cystic carcinoma.Journal of thoracic disease · 2018Article
- Clinicopathological characteristics and molecular analysis of primary pulmonary mucoepidermoid carcinoma: Case report and literature review.Thoracic cancer · 2018Article
- A rare case of endobronchial mucoepidermoid carcinoma of the lung presenting as non-resolving pneumonia.Respiratory medicine case reports · 2018Article
- A Comparative Study of Primary Adenoid Cystic and Mucoepidermoid Carcinoma of Lung.Frontiers in oncology · 2018Article
- Interventional Bronchoscopic Therapy in Adult Patients with Tracheobronchial Mucoepidermoid Carcinoma.Chinese medical journal · 2017Article
- [Mucoepidermoid Carcinoma of the Lung: Report of 29 Cases].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe optimal treatment for pulmonary mucoepidermoid carcinoma (MEC), a rare type of tumor, has not been established yet. This study analyzed the survival of pulmonary MEC patients and attempted to find clues for optimal treatment.
methodsA total of 21 patients with pulmonary MEC from November 2004 to January 2011 were included in the investigation. Immunohistochemistry, epidermal growth factor receptor (EGFR) mutation, and survival were retrospectively studied.
resultsAmong the 21 pulmonary MEC patients, 17 were diagnosed with low-grade malignancy and 4 with high-grade malignancy through pathological examination. The prognosis was found to be poor in the presence of lymph nodes. The expression rates of EGFR and HER2 were 28.6% and 0%, respectively, which correlated with neither grade nor prognosis. The mutation rate of EGFR was 0. Log-rank test results indicated that age, grade, lymph node metastasis, and tumor-node-metastasis stage were prognostic factors.
conclusionAge, grade, lymph node metastasis and tumor-node-metastasis stage correlate with the survival of pulmonary MEC patients.
trial registrationThis study was approved and registered by the Ethics Committee of Zhongshan Hospital. Written informed consent was obtained from all participants prior to treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.